Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2009-06-04
2011-10-11
Babic, Christopher M. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
08034565
ABSTRACT:
The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of breast cancer.
REFERENCES:
patent: 4699877 (1987-10-01), Cline et al.
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5015568 (1991-05-01), Tsujimoto et al.
patent: 5202429 (1993-04-01), Tsujimoto et al.
patent: 5459251 (1995-10-01), Tsujimoto et al.
patent: RE35491 (1997-04-01), Cline et al.
patent: 5670325 (1997-09-01), Lapidus et al.
patent: 5741650 (1998-04-01), Lapidus et al.
patent: 5830665 (1998-11-01), Shuber et al.
patent: 5830753 (1998-11-01), Coulie et al.
patent: 5858678 (1999-01-01), Chinnadurai
patent: 5861278 (1999-01-01), Wong et al.
patent: 5928870 (1999-07-01), Lapidus et al.
patent: 5952178 (1999-09-01), Lapidus et al.
patent: 5952179 (1999-09-01), Chinnadurai
patent: 5962312 (1999-10-01), Plowman et al.
patent: 5985553 (1999-11-01), King et al.
patent: 6001583 (1999-12-01), Margolis
patent: 6020137 (2000-02-01), Lapidus et al.
patent: 6100029 (2000-08-01), Lapidus et al.
patent: 6143529 (2000-11-01), Lapidus et al.
patent: 6146828 (2000-11-01), Lapidus et al.
patent: 6171798 (2001-01-01), Levine et al.
patent: 6203993 (2001-03-01), Shuber et al.
patent: 6207401 (2001-03-01), Plowman et al.
patent: 6207452 (2001-03-01), Govindaswamy
patent: 6214558 (2001-04-01), Shuber et al.
patent: 6245523 (2001-06-01), Altieri
patent: 6248535 (2001-06-01), Danenberg et al.
patent: 6271002 (2001-08-01), Linsley et al.
patent: 6322986 (2001-11-01), Ross
patent: 6414134 (2002-07-01), Reed
patent: 6582919 (2003-06-01), Danenberg
patent: 6602670 (2003-08-01), Danenberg
patent: 6618679 (2003-09-01), Loehrlein et al.
patent: 6620606 (2003-09-01), Bandman et al.
patent: 6696558 (2004-02-01), Reed et al.
patent: 6716575 (2004-04-01), Plowman et al.
patent: 6750013 (2004-06-01), Gish et al.
patent: 6800737 (2004-10-01), Altieri
patent: 6943150 (2005-09-01), Altieri
patent: 7569345 (2009-08-01), Cobleigh et al.
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2002/0004491 (2002-01-01), Xu et al.
patent: 2002/0009736 (2002-01-01), Wang
patent: 2002/0039764 (2002-04-01), Rosen
patent: 2002/0160395 (2002-10-01), Altieri et al.
patent: 2003/0073112 (2003-04-01), Zhang et al.
patent: 2003/0104499 (2003-06-01), Pressman et al.
patent: 2003/0143539 (2003-07-01), Bertucci et al.
patent: 2003/0165952 (2003-09-01), Linnarsson et al.
patent: 2003/0180791 (2003-09-01), Chinnadurai
patent: 2003/0198970 (2003-10-01), Roberts
patent: 2003/0198972 (2003-10-01), Erlander et al.
patent: 2003/0219771 (2003-11-01), Bevilacqua et al.
patent: 2003/0229455 (2003-12-01), Bevilacqua et al.
patent: 2004/0009489 (2004-01-01), Golub et al.
patent: 2004/0126775 (2004-07-01), Altieri et al.
patent: 2004/0133352 (2004-07-01), Bevilacqua et al.
patent: 2005/0260572 (2005-11-01), Kato et al.
patent: 0108564 (1988-05-01), None
patent: 1365034 (2003-11-01), None
patent: WO9902714 (1999-01-01), None
patent: WO0050595 (2000-08-01), None
patent: WO0055173 (2000-09-01), None
patent: WO0055180 (2000-09-01), None
patent: WO0125250 (2001-04-01), None
patent: WO0140466 (2001-06-01), None
patent: WO0155320 (2001-08-01), None
patent: WO0170979 (2001-09-01), None
patent: WO0175160 (2001-10-01), None
patent: WO0200677 (2002-01-01), None
patent: WO0206526 (2002-01-01), None
patent: WO0208260 (2002-01-01), None
patent: WO0208261 (2002-01-01), None
patent: WO0208282 (2002-01-01), None
patent: WO0208765 (2002-01-01), None
patent: W002011897 (2002-02-01), None
patent: WO0210436 (2002-02-01), None
patent: WO0246467 (2002-06-01), None
patent: WO02017852 (2002-07-01), None
patent: WO02055988 (2002-07-01), None
patent: WO02059271 (2002-08-01), None
patent: WO02059377 (2002-08-01), None
patent: WO02068579 (2002-09-01), None
patent: WO02072828 (2002-09-01), None
patent: WO02103320 (2002-12-01), None
patent: WO03078662 (2003-09-01), None
patent: WO03083096 (2003-10-01), None
patent: WO2004074518 (2004-09-01), None
patent: WO2004111603 (2004-12-01), None
patent: WO2009026128 (2009-02-01), None
patent: WO2009140304 (2009-11-01), None
Martin et al. (Cancer Res. Apr. 15, 2000;60(8):2232-8).
U.S. Appl. No. 12/900,388, Baker, Joffre B.
European Search Report issued in EP App. No. 10162868.3 on Aug. 19, 2010, 7 pages.
European Search Report issued in EP App. No. 10162867.5 on Aug. 19, 2010, 8 pages.
JP Patent Application Serial No. 2006-500964, Office Action, dated Jul. 30, 2010. (translation attached).
Rejthar A. The intermediate filaments and prognostically oriented morphological classification in ductal breast carcinoma. Neoplasma, 1997;44(6):370-3.
Proceedings of the Conference of the Japanese Cancer Association, 61st Conference (2002), p. 154 (3134).
Ahmad, et al., “Stromelysin 3: An Independent Prognostic Factor for Relapse: Free Survival in Node-Positive Breast Cancer and Demonstration of Novel Breast Carcinoma Cell Expression”, American Journal of Clinical Pathology, vol. 152, No. 3, pp. 721-728, Mar. 3, 1998.
Bertucci, F., et al. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Human Molecular Genetics. 2000, vol. 9, No. 20, pp. 2981-1991.
Bharracharjee, et al., “Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 24, pp. 13790-13795, Nov. 20, 2001.
Borresen-Dale, et al. “Genetic Profiling of Breast Cancer: From Molecular Portraits to Clinical Utility”, The International Journal of Biological Markers, vol. 18, No. I, pp. 54-56, Sep. 20, 2002.
Brabender, et al. Epidermal Growth Factor Receptor and HER,-neu mRNA Expression in Non-Small Cell Lung Cancer Is Correlated with Survival, Clinical Cancer Research; vol. 7, Jul. 2001; pp. 1850-1855.
Chenard, M., et al. High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma. International Journal of Cancer. 1996, vol. 69, pp. 448-451.
Cambridge Healthtech Institute Conference Agenda; “Enabling Molecular Profiling With Cellular Resolution: Microgenomies Using Homogeneous Cell Samples”; Dee. 2002; 5 pgs.
Ding, et al.; A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS. PNAS, vol. 100:6; Mar. 18, 2003: pp. 3059-30641.
Engel, G., et al. Correlation between stromelysin-3 mRNA and outcome of human breast cancer. International Journal of Cancer. 1994, vol. 58, pp. 830-835.
Forozan, et al., “Comparative Genomic Hybridization Analysis of 38 Breast Cancer Cell Lines: A Basis for Interpreting Complementary DNA Microarray Data”, Cancer Research, vol. 60, No. 16, pp. 45 19-4525, Aug. 15, 2000.
Golub, et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, vol. 286, pp. 531-537, Oct. 15, 1999.
Guerlin, et al.,“Structure and Expression of cerbB2 and EGF Receptor Genes in Inflammatory and Non-Inflammatory Breast Cancer”, International Journal of Cancer, vol. 43, pp. 201-208, 1989.
Kononen, J., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Medicine. 1998, vol. 4, No. 7, pp. 844-847.
Korfee, et al., DNA- Microarray in translational cancer research, Current Pharmacogenomics, 2005. vol. 3, pp. 201-216.
Kroese, et al. Genetic tests and their evaluation: Can we answer the key questions?, Genetics in medicine, vol. 6. pp. 475-480, 2004.
Leek, et al., “Association of Macrophage Infiltration with Angiogenesis and Prognosis in Invasive Breast Carcinoma”, Cancer Research, vol. 56. pp. 4625-4629. Oct. 15, 1996.
Lucentini, Gene association studies typically wrong,The Scientist, vol. 18, p. 20, 2004.
Martin, et al., “Linking Gene Expression Patterns to Therapeutic Groups in Breast Cancer”, Cancer Research, vol. 60,pp. 2232-2238, Apr. 15, 2000.
Murphy, et al., Gene expression profiling in breast cancer: towards individualising patient management, Pathology, 2005, vol. 37(4), pp.
Baker Joffre B.
Cobleigh Melody A.
Cronin Maureen T.
Shak Steven
Babic Christopher M.
Borden Paula A.
Bozicevic Field & Francis LLP
Genomic Health, Inc.
LandOfFree
Gene expression markers for breast cancer prognosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression markers for breast cancer prognosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression markers for breast cancer prognosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4260009